Medicare billing address
CMS Medicare provider billing file
599 W State StSuite 200
Doylestown, PA 18901
CMS public data · NPI 1285693069
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Victor Araya, MD
Specialty
Credential
MD
NPI
1285693069
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Victor Araya, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
599 W State StCMS Doctors & Clinicians file
1811 Bethlehem PikeIn the 2024 CMS provider billing file, this NPI had 509 Medicare beneficiaries and 8,677 total services. The average beneficiary age was 73, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$298,253.50
Total Medicare payment amount
$236,170.05
Medicare beneficiaries
509
Total services
8,677
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Diabetes
31%
CMS beneficiary-panel share
Anxiety
27%
CMS beneficiary-panel share
Chronic kidney disease
26%
CMS beneficiary-panel share
Mood disorders
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, infliximab, excludes biosimilar, 10 mg | 2,410 | $31.40 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 155 | $49.19 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 152 | $131.20 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 136 | $93.18 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 128 | $255.30 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 88 | $64.16 |
| Ultrasound scan of organ tissue for measuring elasticity | 68 | $107.35 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $118.22 |
| Biopsy of large bowel using a flexible endoscope | 48 | $97.34 |
| Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | 38 | $58.16 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1285693069. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Pantoprazole Sodium | Pantoprazole Sodium | 167 | 359 | $1,591.91 |
| 2 | Omeprazole | Omeprazole | 144 | 340 | $1,057.53 |
| 3 | Famotidine | Famotidine | 129 | 291.8 | $1,484.33 |
| 4 | Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | 114.1 | $989.17 |
| 5 | Carvedilol | Carvedilol | 49 | 99 | $434.64 |
| 6 | Dicyclomine Hcl | Dicyclomine Hcl | 40 | 63.9 | $806.24 |
| 7 | Ursodiol | Ursodiol | 33 | 67 | $7,045.17 |
| 8 | Sutab | Sod Sulf/Pot Chloride/Mag Sulf | 32 | 32 | $5,014.76 |
| 9 | Linzess | Linaclotide | 31 | 49 | $25,391.83 |
| 10 | Creon | Lipase/Protease/Amylase | 30 | 33 | $30,506.58 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
George Washington University School Of Medicine
Graduation year
1989
Group/practice field
Regional Gastroenterology Associates Of Lancaster, Ltd.
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.